Diabetic Ulcer Infections

The VeriCyn Wound Wash medical device by Armis Biopharma has received 510(k) clearance from the FDA for use in cleansing wounds of debris, according to a company press release.

Data has indicated thiazolidinedione pioglitazone and GLP-1 receptor agonists improve beta-cell function in patients with diabetes, prompting a meeting presenter to suggest both drugs be used as first-line therapies for the disease.